Kerry A. Morrone

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/66099180-ee0e-11ee-a60f-4f2b57adc1a2.jpg

First Name

Kerry

Last Name

Morrone

NPI

1265734297

Faculty ID

12909

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Anemia, hospitalist medicine, general pediatrics</p>

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Dr. Morrone focuses on classical hematology, particularly sickle cell disease and hemoglobinopathies, platelet disorders, thrombosis, and bone marrow failure syndromes.

Research Focus

Dr. Morrone is committed to improving quality of care and health care utilization in chronic illness, particularly sickle cell disease, and thalassemia through her research

Elsevier Profile

EMR ID

4700

Biography

<p>Kerry Morrone, MD, is an Assistant Professor of Pediatrics at the Albert Einstein College of Medicine, the Director of the Sickle Cell Program and the Director of the Pediatric Hematology Oncology Fellowship Program at Montefiore. Dr. Morrone focuses on classical hematology, particularly sickle cell disease and hemoglobinopathies, platelet disorders, thrombosis, and bone marrow failure syndromes.</p><p>Dr. Morrone graduated from New York University, earning her Bachelor of Arts in Biology in 2003. She then attended the Albert Einstein College of Medicine, where she received her Doctor of Medicine in 2007 and was inducted into the Alpha Omega Alpha Honor Medical Society. Dr. Morrone completed her pediatric residency, chief residency, and pediatric hematology oncology fellowship all at the Albert Einstein College of Medicine. She has also been recognized for her teaching efforts many times and won the Leo M. Davidoff Society &ndash; Albert Einstein College of Medicine Teaching Award in 2010 and 2015.</p><p>Dr. Morrone is committed to improving quality of care and health care utilization in chronic illness, particularly sickle cell disease, and thalassemia through her research. Other current research interests include pulmonary complications of sickle cell disease particularly asthma and acute chest syndrome, in addition to infectious complications and thrombotic complications of sickle cell disease.</p>

Is Open Scheduling

Off

Michal L. Melamed

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/66412790-2b53-11ee-9f8d-1b267177a44e.jpg

First Name

Michal

Last Name

Melamed

NPI

1407953235

Faculty ID

10492

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Michal Melamed is a Professor of Medicine and Epidemiology &amp; Population Health at the Albert Einstein College of Medicine. She has been the Nephrology Fellowship Program Director since 2012. After completing her undergraduate degree in Dramatic Literature at New York University <em>summa cum laude</em>, she trained at Johns Hopkins School of Medicine for medical school, Internal Medicine residency, and Nephrology fellowship. Additionally, she completed a Masters in Clinical Epidemiology from the Johns Hopkins Bloomberg School of Public Health during her fellowship.</p>
<p>She has been continuously funded by the National Institutes of Health since 2007 and her research interests include the epidemiology of chronic kidney disease and its complications, the epidemiology and health consequences of Vitamin D deficiency and metabolic acidosis. Dr. Melamed is the Principal Investigator of several NIH-funded research studies.&nbsp; She has published over 90 original publications in the medical literature and has mentored countless young investigators from high school students to junior faculty members. In 2019, she won the Distinguished Mentor Award from the American Society of Nephrology.</p>
<p>&nbsp;</p>

Research Areas

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p>Selected Publications:<br />&nbsp;<br /><strong>Melamed ML</strong>, Eustace JA, Plantinga L, Jaar BG, Fink NE, Klag MJ, Coresh J, Powe NR. Changes in Serum Calcium, Phosphate and PTH and the Risk of Death in Incident Dialysis Patients: A Longitudinal Study. Kidney Int 2006 Jul;70(2):351-7.<br />&nbsp;<br />Gupta R, Plantinga LC, Fink NE, <strong>Melamed ML</strong>, Coresh J, Fox CS, Levin NW, Powe NR. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA 2007 Apr 4;297(13):1455-64.<br />&nbsp;<br />Hailpern SM, <strong>Melamed ML</strong>, Cohen HW, Hostetter T.&nbsp; Moderate Chronic Kidney Disease and Cognitive Function in Adults 20-59 Years of Age (NHANES III). J Am Soc Nephrol 2007 Jul;18(7):2205-13.<br />&nbsp;<br /><strong>Melamed ML,</strong> Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR. Third-Generation Parathyroid Hormone Assays and All-Cause Mortality in Incident Dialysis Patients: The CHOICE Study. Nephrol Dial Transplant. 2008 May; 23(5):1650-8.</p>
<p><strong>Melamed ML*, </strong>Muntner P*, Michos ED, Uribarri J, Weber C, Sharma J, Raggi P. Serum 25-hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001-2004. Atheroscler Thromb Vasc Biol. 2008 Jun;28(6)1179-85.<br />&nbsp;<br /><strong>Melamed ML*, </strong>Michos ED*, Post W, Astor B. 25-Hydroxyl Vitamin D Levels and the Risk of Mortality in the General Population. Arch Intern Med. 2008 Aug 11;168(15):1629-37.<br />&nbsp;<br />Shah S, Abramowitz M, Hostetter TH, <strong>Melamed ML</strong>. Serum Bicarbonate Levels and the Progression of Kidney Disease: A Cohort Study. Am J Kidney Dis. 2009 Aug;54(2):270-7.<br />&nbsp;<br />Kumar J, Muntner P, Kaskel FJ, Hailpern SM, <strong>Melamed ML</strong>. Prevalence and Associations of 25- Hydroxyvitamin D Deficiency in Children and Adolescents in the United States: Results from NHANES 2001-2004. Pediatrics. Aug 3 2009. Electronic pages.<br />&nbsp;<br />Plantinga LC, Fink NE, Coresh J, Sozio SM, Parekh RS, <strong>Melamed ML</strong>, Powe NR, Jaar BG. Peripheral vascular disease-related procedures in dialysis patients: predictors and prognosis. Clin J Am Soc Nephrol. 2009 Oct;4 (10):1637-45.<br />&nbsp;<br />Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, <strong>Melamed ML</strong>, Wiebe N, Muntner P. Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality. Circulation. 2009 Oct. 19 Epub. 2009 Nov 3;120(18):1784-92.<br />&nbsp;<br /><strong>Melamed ML</strong>, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P. 25-Hydroxyvitamin D levels, Race and the Progression of Kidney Disease. J Am Soc Nephrol. 2009 Dec.;20(12) 2631-9.<br />&nbsp;<br />Abramowitz M, Muntner P, Coco M, Southern W, Lotwin I, Hostetter TH, <strong>Melamed ML</strong>. Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization. Clin J Am Soc Nephrol. 2010 Apr 8 Epub. 2010 Jun;5(6):1064-71.<br />&nbsp;<br />Murea M, Park JK, Sharma S, Kato H, Gruenwald A, Niranjan T, Si H, Thomas DB, Pullman JM, <strong>Melamed ML</strong>, Susztak K. Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int. 2010 June 9; 78(5):514-22.<br />&nbsp;<br /><strong>Melamed ML, </strong>Blackwell T, Neugarten J, Arnsten J, Ensrud K, Ishani A, Cummings S, Silbiger S. Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis. Kidney Int. 2011 Jan;79(2):241-9<br /><strong>&nbsp;</strong><br />O&rsquo; Seaghdha CM, Hwang S-J, Muntner P, <strong>Melamed ML</strong>*, Fox CS*. Serum phosphorus predicts incident Chronic Kidney Disease and End-Stage Renal Disease. Nephrol Dial Transplant 2011 Sep;26(9):2885-90. Epub 2011 Feb 3.<br />&nbsp;<br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. Association of Serum Bicarbonate Levels with Gait Speed and Quadriceps Strength in Older Adults. Am J Kidney Dis 2011 Feb 25.<br />&nbsp;<br />Sharief S, Jariwala S, Kumar J, Muntner P, <strong>Melamed ML</strong>. Vitamin D levels and food and environmental allergies in the United States: Results from NHANES 2005-6. Journal of Allergy and Clinical Immunology 2011 May;127(5):1195-202. Epub 2011 Feb 16. PMID: 21329969<br />&nbsp;<br />Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, <strong>Melamed ML</strong>. Association of Glucocorticoid Use and Low 25-Hydroxyvitamin D Levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab. 2011 Sept 28. (Epub)<br />&nbsp;<br />Michos ED, Reis JP, Post WS, Lutsey PL, Gottesman RF, Mosley TH, Sharrett AR, <strong>Melamed ML</strong>. 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES III linked mortality files. Nutrition 2012 Apr; 28(4)367-71.<br />&nbsp;<br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adults. Kidney International. 2012 May;81(10):103342. Epub 2012 Feb 1. PMCID: PMC3340439<br />&nbsp;<br />Abramowitz MK, Hostetter TH, <strong>Melamed ML</strong>. The serum anion gap is altered in early kidney disease and associates with mortality. Kidney International. 2012 Sep;82 (6):701-9.<br />&nbsp;<br />Abramowitz MK, <strong>Melamed ML</strong>, Bauer C, Raff AC, Hostetter TH. Effects of Oral Sodium Bicarbonate in Patients with CKD. Clinical Journal of the American Society of Nephrology. 2013 Feb 7^th Epub ahead of print. 2013 May; 8(5)714-20.<br /><br /><strong>Melamed ML</strong>, Plantinga L, Shafi T, Parekh R, Meyer TW, Hostetter TH, Coresh J, Powe NR. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators. BMC Nephrol 2013 June 27;14(1)134.<br />&nbsp;<br />Milman S, Schulder-Katz M, Deluty J, Zimmerman ME, Crandall JP, Barzilai N, <strong>Melamed ML*</strong>, Atzmon G*.&nbsp; Individuals with Exceptional Longevity Manifest a Delayed Association Between Vitamin D Insufficiency and Cognitive Impairment. J Am Geriatr Soc. 2014 Jan Epub.<br />&nbsp;<br />Akchurin OM, <strong>Melamed ML</strong>, Hashim BL, Kaskel FJ, Del Rio M. Medication adherence in the transition of adolescent kidney transplant recipients to the adult care. Pediatric Transplantation. 2014 May 12 Epub. 18(5):538-48.<br />&nbsp;<br />Chen W, <strong>Melamed ML</strong>, Abramowitz MK. Serum bicarbonate and Bone Mineral Density in US Adults. Am J Kidney Dis. 2014 Aug 26 Epub. 2015 Feb;65(2):240-8.&nbsp;<br />&nbsp;<br />Sarathy H, Pramanik V, Kahn J, Abramowitz MK, Meier K, Kishore P, <strong>Melamed ML</strong>. The Effects of Short-term Vitamin D Supplementation on Glucose Metabolism in Dialysis Patients: A Systematic Review and Meta-Analysis.&nbsp; Int Urol Nephrol. 2015 Mar;47(3):537-49.&nbsp;<br />&nbsp;<br />Barry EL, Mott LA, <strong>Melamed ML,</strong> Rees JR, Ivanova A, Sandler RS, Ahnen DJ, Bresalier RS, Summers RW, Bostick RM, Baron JA. Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One. 2014. Oct 15;9(10):e108094.<br />&nbsp;<br />Calp-Inal S, Ajaimy M, <strong>Melamed ML</strong>, Savchik C, Masiakos P, Colovai A, Akalin E. The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation.&nbsp; Kidney Int 2015 Nov 4 (Epub ahead of print)<br />&nbsp;<br />Kumar J, McDermott K, Abraham AG, Friedman LA, Johnson VL, Kaskel FJ, Furth SL, Warady BA, Portale AA, <strong>Melamed ML. </strong>Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKID) cohort. Pediatr Nephrol. 2016 Jan; 31(1):121-9.</p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-no-proof: yes;">Chen W, <strong>Melamed ML</strong>, Hostetter TH, Bauer C, Raff AC, Almudevar AL, Lalonde A, Messing S, Abramowitz MK. Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study. <em>BMC Nephrol. </em>2016;17(1):114.</span></p>
<p><span style="text-indent: -0.25in; font-size: 11pt; font-family: Arial, sans-serif;">Shafi T, Powe NR, Meyer TW, Hwang S, Hai X, <strong>Melamed ML</strong>, Banerjee T, Coresh J, Hostetter TH. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. <em>J Am Soc Nephrol. </em>2017 Jan;28(1):321-31.</span></p>
<p><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-bidi-font-weight: bold;">Goel N, Kwon C, Zachariah TP, Broker M, Folkert VW, Bauer C, <strong>Melamed ML</strong>. Vascular access placement in patients with chronic kidney disease stages 4 and 5 attending an inner city nephrology clinic: a cohort study and survey of providers.&nbsp; <em>BMC Nephrol</em>. 2017; 18(1):28.</span></p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">Buttar RS, Batra J, Kreimerman J, Aleta M, <strong>Melamed ML</strong>. Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels. J Gen Intern Med. 2017 Oct;32(10):1156-1159.</span></p>
<p><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-bidi-font-weight: bold;">Golestaneh L Bellin E, Southern W, <strong>Melamed ML</strong>. Discharge service as a determinant of 30-day readmission in a cohort of maintenance hemodialysis patients: a retrospective cohort study. BMC Nephrol. 2017 Dec 4;18(1):352.</span></p>
<p><strong><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">Melamed ML</span></strong><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">, Chonchol M, Gutierrez OM, Kalantar-Zadeh K, Kendrick J, Norris K, Scialla JJ, Thadhani R. The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2018; 72(6)834-845.</span></p>
<p><span style="font-size: 11.0pt; font-family: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;">Astor BC, Djamali A, Mandelbrot DA, Parajuli S, <strong>Melamed ML</strong>. The Association of 25-hydroxyvitamin D Levels with Late Cytomegalovirus Infection in Kidney Transplant Recipients: the Wisconsin Allograft Recipient Database (WisARD). Transplantation</span> <span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">2019 Aug;103(8):1683-1688</span></p>
<p><span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="font-size: 11pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Chen W, Eisenberg R, Mowrey WB, Wylie-Rosett J, Abramowitz MK, Bushinsky DA, <strong>Melamed ML</strong>.&nbsp; Association between dietary zinc intake and abdominal aortic calcification in US adults. Nephrol Dial Transplant. 2019 Jul 11.</span></span></p>
<p><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">Sochol KM, Johns TS, Buttar RS, Randhawa L, Sanchez E, Gal M, Lestrade K, Merzkani M, Abramowitz MK, Mossavar-Rahmani Y, </span><strong style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">Melamed ML</strong><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;">. The Effects of Dairy Intake on Insulin Resistance: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients 2019; 11(9):2237.</span></p>
<p><span style="font-family: Arial, sans-serif; font-size: 11pt; text-indent: -0.25in;"><strong>Melamed ML</strong>, Horwitz EJ, Dobre MA, Abramowitz MK, Zhang L, Lo Y, Mitch WE, Hostetter TH. The Effects of Sodium Bicarbonate in Chronic Kidney Disease Stages 3 and 4: A Randomized, Placebo-Control, Multi-Center Clinical Trial. American Journal of Kidney Diseases. 2020.</span></p>
<p>&nbsp;</p>

EMR ID

4836

Is Open Scheduling

Off

Maria Y. Mazing

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Maria

Last Name

Mazing

NPI

1598877276

Faculty ID

10864

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>My research interest is in internal medicine/hospital medicine.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4934

Is Open Scheduling

Off

Luz E. Liriano-Ward

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/ccab2620-3cad-11ec-80f7-67047826a941.jpg

First Name

Luz

Last Name

Liriano-Ward

NPI

1801020896

Faculty ID

15436

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Kidney and Pancreas Transplantation

Research Focus

Short term and long term outcomes of deceased donor kidney transplantation. Pancreas transplant outcomes on Type 2 diabetics compared to type 1 diabetics. The use of SGLT2- inhibitor in kidney transplant recipients.&nbsp;

Elsevier Profile

EMR ID

3120

Biography

Luz Liriano-Ward, MD received her MD degree at Weill Cornell Medical College. She then completed internal medicine residency at NYU Langone Medical Center, followed by 2-years of nephrology fellowship and 1 year of transplant nephrology at Mount Sinai Hospital &ndash; Icahn School of Medicine. Dr. Liriano-Ward is a UNOS certified transplant nephrologist. Dr. Liriano-Ward is board certified by the American Board of Internal Medicine and the American Board of Nephrology. Dr. Liriano-Ward is a member of the American Society of nephrology and the American Society of Transplantation. She has special interest in medical education and acts as the director for the transplant nephrology fellowship at Montefiore Medical Center. She is also the director for the medical students&rsquo; nephrology rotation at Albert Einstein College of medicine / Montefiore Medical Center. She serves in multiple committees at the local and national level, including the Transplant Nephrology Fellowship Training Accreditation Program (TNFTAP) for the American Society of Transplantation.&nbsp;

Is Open Scheduling

Off

Neelja D. Kumar

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f076dd00-43b4-11ee-a7f9-01ad5bafacad.jpg

First Name

Neelja

Last Name

Kumar

NPI

1396911236

Faculty ID

14242

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Chronic Kidney Disease, Renal disease associated with pregnancy, diabetic kidney disease, acute kidney injury, hypertension

Research Focus

Clinical Nephrology and Education

Elsevier Profile

EMR ID

69712

Biography

Neelja Kumar, MD, earned her medical degree at Sophie Davis School of Biomedical Education with Stonybrook Medical Center, New York. She completed her clinical fellowship in Nephrology at Yale School of Medicine, New Haven Connecticut. Dr. Kumar completed her residency in internal medicine at New York University Langone Medical Center and then went on to complete an additional year as chief resident. Dr. Kumar is a board-certified nephrologist and has been part of the faculty at Montefiore since 2014. Dr. Kumar serves as Medical Director at an outpatient dialysis unit in the Bronx. Additionally, Dr. Kumar is an Associate Program Director for the nephrology fellowship program and has worked to enrich the academic curriculum for the clinical fellows. <span style="color:#000000;font-family:Inter, sans-serif;font-size:13.125px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;letter-spacing:normal;orphans:2;text-align:start;text-indent:0px;text-transform:none;widows:2;word-spacing:0px;-webkit-text-stroke-width:0px;white-space:pre-wrap;background-color:#f5f5f4;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;display:inline !important;float:none;">Her clinical interests within nephrology include renal disease in the critically ill population and renal disease during pregnancy.</span>

Visit Type ID

2541

Is Open Scheduling

On

Iyad Kejo

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/8b096120-5efc-11ec-bfce-d5e3d9116b93.jpg

First Name

Iyad

Last Name

Kejo

NPI

1821479148

Faculty ID

16940

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

14043

Is Open Scheduling

Off

Ross I. Kaye

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Ross

Last Name

Kaye

NPI

1568737831

Faculty ID

18024

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

78694

Is Open Scheduling

Off

Frederick J. Kaskel

https://assets.montefioreeinstein.org/profiles/images/physphoto/Kaskel_Frederick_MD_420x504-2.jpg

First Name

Frederick

Last Name

Kaskel

NPI

1699851535

Faculty ID

3451

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Frederick J. Kaskel, M.D., Ph.D., is an internationally recognized clinical investigator and educator in pediatric nephrology. He is a Chief Emeritus, Nephrology Children's Hospital at Montefioire, Albert Einstein College of Medicine. He is a Past President of the American Society of Pediatric Nephrology and the Congress President of the 15th Scientific Congress of the International Pediatric Nephrology Association.</p>
<p>He received his undergraduate bachelor's degree in Biology from Monmouth College, Monmouth, Ill., and his doctorate in Physiology and Medical Degree from the University of Cincinnati College of Medicine and is a Distinguished Alumnus from both of these institutions. He trained in Pediatrics and Pediatric Nephrology at Montefiore Medical Center and Albert Einstein College of Medicine, respectively and was a recipient of an NIH National Research Service Award. Prior to returning to Montefiore Medical Center and the Albert Einstein College of Medicine in 1998 to become the Director of Pediatric Nephrology, he was a tenured Professor of Pediatrics at the State University of New York at Stony Brook.</p>
<p>Dr. Kaskel's research interests range from basic science contributions in developmental renal physiology and mechanisms of renal toxicity and hypertension, to clinical and translational research in the etiologies and treatment of progressive kidney diseases secondary to nephrotic sydnrome and focal segmental glomerulosclerosis and hypertension. His current research is aimed at preventing the epidemic of obesity and cardiovascular risk factors and hypertension. He has received continuous research support from the National Institutes of Health and directs the Training Program in Pediatric Nephrology which prepares new physician investigators for careers in Pediatric Nephrology.</p>
<p>He published over 100 peer-reviewed articles, book chapters, and co-edited a major textbook on Fluids and Electrolytes in Pediatrics. He has numerous collaborations nationally and internationally and is expanding the communications between pediatric nephrology basic and clinical investigators worldwide. He currently plays a major role representing the Department of Pediatrics in the Einstein's prestigious Clinical Translational Science Award.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Kidney disorders in infants, children and adolescents; end-stage kidney replacement therapy and transplantation

Research Focus

Prevention of kidney disease progression; prevention of hypertension and cardiovascular disease

Elsevier Profile

Selected Publications

<div class="WordSection1">
<ol start="1">
<li>Chandra M, Stokes MB, Kaskel FJ. Multinucleated podocytes: a diagnostic clue to cystinosis. Kidney Int. 2010 Nov;78(10):1052. PMID 21030980</li>
<li>Greenbaum LA, Munoz A, Schneider MF, kaskel FJ, Askenazi DJ, Jenkins R, Hotchkiss H, Moxey-Mims M, Furth SL, Warady BA. The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol 011 Jan;6(1):14-21. PMC3022235</li>
<li>Gipson DS, Trachtman H, Kaskel FJ, Radeva MK, Gassman J, Greene TH, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Middelton JP, Vehaskari VM, Hogan SL, Vento S, Flynn PA, Powell LM, McMahan JL, Siegel N, Friedman AL. Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. Kidney Int. 2011 Mar;79(6):678-85. PMC3306823</li>
<li>Goilav B, Kaskel FJ. Chronic kidney disease stages are appropriate at all ages.&nbsp; Blood Purif. 2011;31(1-3):125-&nbsp;&nbsp; 129. PMID 21228580</li>
<li>Thomas R, Sanna-Cherchi S, Warady BA, Furth SL, Kaskel FJ, Gharavi AG. HNF1B and PAX2 mutations are a common cause of renal hypodysplasia in the CKiD cohort. Pediatr Nephrol. 2011 Jun;26(6):897-903. PMC3257470</li>
</ol>
</div>
<div class="WordSection2">
<ol start="6">
<li>Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, Moxey-Mims MM, Hogg RJ,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Watkins SL, Fine RN, Hogan SL, Middleton JP, Vehaskari VM, Flynn PA, Powell LM, Vento SM, McMagan JL, Siegel N, D&rsquo;Agati VD, Friedman AL.&nbsp; Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int. 2011 Oct;80(8):868-78. PMC3306824</li>
<li>Furth SL, Abraham AG, Jerry-Fluker J, Schwartz GJ, Benfield M, Kaskel F, Wong C, Mak RH, Moxey-Mims M, Warady BA. Clin J Am Soc Nephrol. 2011 Sep;6(9):2132-40. PMC3358991</li>
<li>Gipson DS, Trachtman H, KaskelFJ, RadevaM, GassmanJ, GreeneT, Moxey-Mims M, HoggR, WatkinsS, FineR, MiddletonJ, VehaskariVM, HoganHL, VentoS, FlynnP, PowellL, McMahanJ, SiegelN, FriedmanA. Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. Kidney Int. 2011 Mar; 79(6):678-85. PMC33068223</li>
<li>Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, Melamed ML. Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Surevey (NHANES):2001-2006. J Clin Endocrinol Metab. 2011 Sep28. PMC3232615</li>
<li>D&rsquo;Agati V.D., Kaskel, FJ, and Falk RJ. Medical Progress: Focal Segmental Glomerulosclerosis. New England Journal of Medicine 2011 Dec: 365(25):2398-411. PMID 22187987</li>
<li>Wei C, Trachtman H, Li J, Dong, C, Friedman AL, Gassman JJ, McMahan JL, Radeva M, Heil KM,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Trautmann A, Anaret A, Emre S, Ghiggeri GM, Ozaltin F, Haffner D, Gipson DS, Kaskel, F, Fischer DC,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Schaefer F, Reiser, J. Circulating suPAR in two cohorts of primary FSGS. Clin J Am Soc Nephrol. 23:, 2012.</li>
<li>D&rsquo;Agati VD, Alser JC, Jennette C, Thomas D, Pullman J, Savino D, Cohen A, Gipson D, Gassman J, Radeva M, Moxey-Mims M, Friedman A, Kaskel F, Trachtman H, Alpers C, Fogo A, Nast C. Histologic Variants in FSGS Clinical Trial biopsies correlate with outcome independent of remission status. Clin J Am Soc Nephrol. 2013; Mar;8(3):399-406. PMID: 23220425</li>
<li>Hogg R, Friedman A, Greene T, Radeva M, Budisavljevic M, Gassman J, Gipson D, Jefferson A, John E,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kaskel F, Moudgil A, Moxe-Mims M, Ortiz L, Schelling J, Schnaper H, Srivastava T, Trachtman H,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vehaskari V, Wong C, Worinicki R, Van Wy S, Zolotnitskaya A. Renal function and proteinuria after&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; successful immunosuppressive therapies in patients with focal segmental glomerulosclerosis (FSGS).&nbsp; Clin J Am Soc Nephrol. 2013 Feb;8(2):211-8. PMID: 23143503</li>
<li>Ferris M, Norwood V, Radeva M, Gassman J, Amira A, Askenazi D, Mato T, Pinsk M, Sharma A, Smoyer W, Stults J, Vyas S, Weiss R, Gipson D, Kaskel F, Friedman A, Moxey-Mins M, Trachtman H. Patient&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; recruitment in a multicenter randomized clinical trial for kidney disease: report of the Focal Segmental&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Glomerulosclerosis Clinical Trial. Clin Trans Sci 2013 Feb;6(1):13-20. PMID: 23399084</li>
<li>Gadegbeku C, Gipson D, Holzman L, Ojo A, Song P, Barisoni L, Sampson M, Kopp J, Lemley K, Nelson P, &nbsp;Lienczewski C, Adler S, Appel G, Cattran D, Choi M, Contreras G, Dell K, Fervenza F,&nbsp; Gibson K, Greenbaum L, Hernandez J, Hewitt S, Hingorani S, Hladunewich M, Hogan M, Hogan S, Kaskel J,&nbsp; Lieske J, Meyers K, Nachman P, Nast C, Neu A, Reich H, Sedor J, Sethna C, Trachtman H, Tuttle K, Zilleruelo G, and Kretzler M. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney International advance online publication, 16 January 2013 doi:10.1038/ki.2012.428.</li>
<li>Akchurin O, Kaskel FJ. Late steroid resistance in childhood nephrotic syndrome: do we now know more that 40 years ago? Pediatr Nephrol. 2013 Aug;28(8):1157-60. PMID: 23708761</li>
<li>&nbsp;&nbsp; 17. Frederick Kaskel, Daniel Batlle, Srinivasan Beddhu, John Daugirdas, Harold Feldman, Maria Ferris, &nbsp; Lawrence Fine, Barry Freedman, Paul L Kimmel, Michael F Flessner, Robert A. Star, on behalf of the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kidney Research National Dialogue (KRND). Improving CKD Therapies and Care: A National Dialogue. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CJASN (In Press).</li>
<li>18. Nephropathic Cystinosis: An International Consensus Document. NDT (in Press).</li>
</ol>
</div>
<p><strong>&nbsp;</strong></p>

EMR ID

4171

Biography

<p>As Director of the Division of Pediatric Nephrology, Dr. Kaskel is involved in basic and clinical investigations into the mechanisms of the major kidney disorders in pediatrics. He is particularly interested in the physiology and pathophysiology of normal and abnormal development and function of the kidneys throughout the critical periods of growth and maturation extending into adolescence and young adulthood. He is actively involved in a clinical trial funded by the National Institutes of Health (NIH) to find the most efficacious therapy for focal segmental glomerulosclerosis, one of the major causes of progressive glomerular disease, while investigating the molecular etiologies for its expression. Another NIH-supported study involves chronic kidney disease in children and how it affects their growth and neurocognitive development, and the risk factors for cardiovascular disease and renal progression.</p><p>Dr. Kaskel is a past president of the American Society of Pediatric Nephrology, was Congress President of the International Pediatric Nephrology Association 15th Scientific Meeting, and has served as Chair for the Council of Nephrology and Urology of the National Kidney Foundation and the Kidney and Urology Foundation of America. He has also served on the Cardiovascular Renal Advisory Panel of the Food and Drug Administration (FDA) and as Associate Editor for the <em>Journal of the IPNA Pediatric Nephrology</em>. In addition, he has been named one of the Best Doctors in America and New York and as a Super Doctor by <em>New York Times</em> Magazine.</p>

Is Open Scheduling

On

Zocdoc Link

Mahsa Kanzali

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Mahsa

Last Name

Kanzali

NPI

1295122661

Faculty ID

18306

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

76958

Is Open Scheduling

Off

Grace R. Kajita

https://assets.montefioreeinstein.org/profiles/images/physphoto/Kajita_Grace_MD_420x504.jpg

First Name

Grace

Last Name

Kajita

NPI

1235176991

Faculty ID

14657

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Kajita completed a bachelor's degree at Barnard College, Columbia University, a medical degree at Albert Einstein College of Medicine, and a primary care medicine residency at NYU School of Medicine. Following residency she became an attending physician for the Department of Veterans' Affairs, New York Harbor Healthcare, where she also served as firm chief for the Department of Medicine and associate program director for the Internal Medicine Residency. In 2005, she was appointed clinical instructor of medicine at NYU Langone Medical Center, where she also served as associate program director for the Internal Medicine Residency. Dr. Kajita's broad range of teaching, administrative, and clinical experience includes the development of a global health elective for internal medicine residents and service as a TB unit supervisor and medical referent for M&eacute;decins Sans Fronti&egrave;res in South Sudan. She is a fellow of the American College of Physicians, MSF-USA Association, and the Association of Program Directors in Internal Medicine. Additionally, Dr. Kajita has received multiple teacher-of-the-year awards at NYU.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

73271

Is Open Scheduling

On